Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Accelerated Phase 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gastrointestinal Stromal Tumors 1 Breast Neoplasms 1

Interventions

pembrolizumab 3 fludarabine 3 Cyclophosphamide 3 Ipilimumab 2 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 sargramostim 1 reolysin 1 poly ICLC 1 peginterferon alfa-2a 1 osimertinib 1 gusacitinib 1 fludarabine phosphate 1 eprenetapopt 1 epacadostat 1 dabrafenib 1 cobimetinib 1 cemiplimab 1 Vorinostat 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Poly I-C 1 Nivolumab 1 Monatide (IMS 3015) 1 Methods 1 MAPRE1 protein, human 1 Interleukin-2 1 Interleukin-15 1 Interleukin-12 1 IT-101 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Skin Neoplasms × Blood Specimen Collection × Clear all

NCT07422805 2026-05-27

ctDNA

Institute of Oncology Ljubljana

Phase 1/2 Active not recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡